Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update for amrubicin in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel/carboplatin with or without CDP791 in non-squamous non-small cell lung cancer completed.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV [Phase 2]
A Phase 2 pharmacogenomic study aimed at personalizing treatment strategies for advanced non-small cell lung cancer (NSCLC) has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). [Phase 3]
A phase 3 trial (POSEIDON) comparing durvalumab + tremelimumab with chemotherapy versus durvalumab with chemotherapy and chemotherapy alone …
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10% [Phase 2]
Phase 2 trial update evaluating nivolumab after cyclophosphamide and doxorubicin induction in NSCLC with PD-L1 <10%. Status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer [Phase 4]
A Phase 4 clinical trial update assessing efficacy and safety of platinum gemcitabine with Cindilimab in first-line advanced squamous non-sm…
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) [Phase 2]
Phase 2 trial update on neoadjuvant pembrolizumab + ramucirumab for PD-L1 positive stage IB-IIIA non-small cell lung cancer (EAST ENERGY).
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Study of Lorlatinib in ROS1 Rearranged NSCLC [Phase 2]
Phase 2 trial update of lorlatinib in ROS1-rearranged non-small cell lung cancer (NSCLC) is cited with unknown current status.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations [Phase 2]
Phase 2 trial update investigating neoadjuvant erlotinib for operable NSCLC with EGFR mutations (Stage II/IIIA).
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+) [Phase 2]
Phase 2 trial comparing Tarceva to Avastin+Tarceva for EGFR-positive non-small cell lung cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC [Phase 2]
Phase 2 trial assessing BIBW 2992 (afatinib) plus simvastatin versus BIBW 2992 alone in previously treated advanced non-adenocarcinomatous n…
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating sintilimab plus anlotinib for initially unresectable non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC) [Phase 3]
A Phase 3 clinical trial update for TQB2450 in Stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors [Phase 2]
Phase 2 trial exploring DPX-Survivac with low-dose cyclophosphamide and pembrolizumab in selected advanced solid tumors; currently active/no…
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy [Phase 2]
A single-arm Phase II trial evaluating pemigatinib in advanced non-small cell lung cancer patients with FGFR alterations after failure of st…
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for TQ-B3525 tablets combined with osimertinib in advanced non-small cell lung cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor [Phase 2]
Phase 2 study evaluating capmatinib in NSCLC patients with MET exon 14 alterations who previously received a MET inhibitor has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations [Phase 2]
Phase 2 trial evaluating lazertinib in NSCLC patients with uncommon EGFR mutations is ongoing with status not yet determined.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 safety study of nivolumab in advanced or metastatic non-small cell lung cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating neo-adjuvant treatment in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers [Phase 1]
Phase 1 trial assessing cabiralizumab with nivolumab in selected advanced cancers has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating gefitinib with or without chemotherapy in brain metastases from non-small cell lung cancer is ongoing; results not …
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC). [Phase 2]
Phase 2 clinical trial update for Immunopheresis alone or in combination with paclitaxel or atezolizumab in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy [Phase 1, Phase 2]
Phase 1/2 trial investigating neoadjuvant durvalumab (MEDI4736) followed by radical radiotherapy or chemoradiotherapy in non-surgical early …
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Sintilimab Combined With Docetaxel for Standard Chemotherapy Failure Non-driver Gene Mutation Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating sintilimab with docetaxel for non-driver gene mutation metastatic non-small cell lung cancer after standard …